Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

Formica Vincenzo; Montefusco Eugenio; Roselli Mario

首页> 外文期刊>Cancer biology & therapy >Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

【24h】

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

机译：是否有其他方法可以量化新型药物在肿瘤学中的真正益处？ -“死亡步伐”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer biology & therapy》 |2015年第2期|共2页
作者
Formica Vincenzo; Montefusco Eugenio; Roselli Mario;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace' [J] . Formica Vincenzo, Montefusco Eugenio, Roselli Mario Cancer biology & therapy . 2015,第2期

机译：是否有其他方法可以量化新型药物在肿瘤学中的真正益处？ -“死亡步伐”
2. Appraisal of Innovative Anticancer Agents: Do the Scores of European Society for Medical Oncology-Magnitude of Clinical Benefit Scale and American Society of Clinical Oncology Task Force Correlate With Survival Gains? [J] . Messori Andrea, Trippoli Sabrina, Marinai Claudio Journal of Clinical Oncology . 2017,第10期

机译：对创新抗癌代理的评估：欧洲医学肿瘤学会的成绩是否为临床福利规模和美国临床肿瘤学会的美国学会与生存收益相关联？
3. Appraisal of Innovative Anticancer Agents: Do the Scores of European Society for Medical Oncology-Magnitude of Clinical Benefit Scale and American Society of Clinical Oncology Task Force Correlate With Survival Gains? (vol 35, pg 1137, 2017) [J] . Messori Journal of Clinical Oncology . 2017,第14期

机译：对创新抗癌代理的评估：欧洲医学肿瘤学会的成绩是否为临床福利规模和美国临床肿瘤学会的美国学会与生存收益相关联？（Vol 35，PG 1137,2017）
4. Quantifying benefits of alternative home delivery operations on transport in China [C] . Liying Song, Jun Wang, Cong Liu, International conference on control, automation and systems . 2016

机译：量化替代性送货上门业务在中国运输中的收益
5. Quantifying the Benefits of Farm Level Utilization of Alternative Marketing Arrangement. [D] . Hu, Wu-Yueh. 2010

机译：量化农场利用替代市场营销安排的收益。
6. Are there alternative ways to quantify the real benefit of novel agents in oncology? – the ‘death pace’ [O] . Vincenzo Formica, Eugenio Montefusco, Mario Roselli 2015

机译：是否有其他方法可以量化新型药物在肿瘤学中的真正益处？ –死亡速度
7. Are there alternative ways to quantify the real benefit of novel agents in oncology? - The 'death pace' [O] . Formica, V, Montefusco, E, Roselli, M 2015

机译：是否有其他方法可以量化新型药物在肿瘤学中的真正益处？ -“死亡步伐”
8. Laser-Induced Breakdown Spectroscopy (LIBS) for Real-Time Detection of Halon Alternative Agents [R] . Williamson, C. K. , Daniel, R. G. , McNesby, K. L. , 1999

机译：用于实时检测哈龙替代药剂的激光诱导击穿光谱（LIBs）

Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'

著录项

相似文献

相关主题

期刊订阅